1) Ammon-treiber S, Holt V:Morphine-induced changes of gene expression in the brain. Addict Biol 10:81-89, 2005
2) Backmund M, Meyer K, Eichenlaub D, et al:Predictors for completing an inpatient detoxification program among intravenous heroin users, methadone substituted and codeine substituted patients. Drug Alcohol Depend 64:173-180, 2001
3) Brown R:Heroin Dependence. WMJ 103:20-26, 2004
4) Darke S, Ross J:Suicide among heroin users:Rates, risk factors and methods. Addiction 97:1383-1394, 2002
5) 一ノ瀬真琴,倉田健一,清水賢,他:本邦におけるMDMA関連精神障害の乱用背景・診断・治療の検討.精神医学 46:1105-1112,2004
6) Jenkins AJ, Oyler JM, Cone EJ:Comparison of heroin and cocaine concentrations in saliva with concentrations in blood and plasma. J Anal Toxicol 19:359-374, 1995
7) Kintz P, Tracqui A, Mangin P, et al:Sweat testing in opioid users with a sweat patch. J Anal Toxicol 20:393-397, 1996
8) 厚生労働省医薬食品局監視指導・麻薬対策課:麻薬・覚せい剤行政の概況.pp75-149,2005
9) 小沼杏坪:覚せい剤と関連精神障害C.治療.佐藤光源,洲脇寛 責任編集,臨床精神医学講座8 薬物・アルコール関連障害.中山書店,pp236-253,1999
10) 小沼杏坪:薬物精神障害の診断基準.日本アルコール精神医学雑誌 8:45-51,2001
11) 小沼杏坪:精神刺激薬(cocaineとmethamphetamine)による精神障害の臨床特徴と治療.臨精薬理 6:1121-1129,2003
12) 倉田健一,山脇成人:特集うつ病の治療「薬物によるうつ病」.医学と薬学 49:847-852,2003
13) Kurata K, Takebayashi M, Morinobu S, et al:b-Estradiol, dehydroepiandrosterone and dehydroepiandrosterone-sulfate protect against NMDA-induced neurotoxicity in rat hippocampal neurons. J Pharmacol Exp Ther 311:237-245, 2004
14) 倉田健一,田村達辞,近藤直樹,他:薬物(アルコールも含む)関連精神障害に関する精神科医師の意識調査結果について.日本精神科救急学会総会雑誌 9:102-106,2006
15) Langendam MW, van Brussel GH, Coutinho RA, et al:The impact of harm-reduction-based methadone treatment on mortality among heroin users. 91:774-780, 2001
16) Liao D, Lin H, Law PY, et al:Mu-opioid receptors modulate the stability of dendritic spines. Proc Natl Acad Sci U S A 102:1725-1730, 2005
17) Lind J, Oyefeso A, Pollard M, et al:Death rate from use of ecstasy or heroin. Lancet 354:2167, 1999
18) Mark TL, Woody GE, Juday T, et al:The economic costs of heroin addiction in the United States. Drug Alcohol Depend 61:195-206, 2001
19) Narita M, Aoki T, Yajima Y, et al:Involvement of protein kinase Cgamma isoform in morphine-induced reinforcing effects. Neuroscience 103:309-314, 2001
20) Nestler EJ, Hope BT, Widnell KL:Drug addiction:A model for the molecular basis of neural plasticity. Neuron 11:995-1006, 1993
21) 千貫悟,小沼杏坪:薬物依存症の外来治療.精神医学 37:841-843,1995
22) Suzuki T, Funada M, Narita M, et al:Morphine-induced place preference in the CXBK mouse:Characteristics of μ opioid receptor subtypes. Brain Res 602:45-52, 1993
23) 鈴木勉:がん性疼痛とモルヒネ:モルヒネの副作用と依存性.Pain Clinic 25:186-195,2004
24) United nations international drug control programme:World drug report. Oxford University Press, New York, pp1-33, 1997
25) Valjent E, Pascoli V, Svenningsson P, et al:Regulation of a protein phosphatase cascade allows convergent dopamine and glutamate signals to activate ERK in the striatum. Proc Natl Acad Sci U S A 102:491-496, 2005
26) 和田清:依存性薬物乱用者・精神病の最近の疫学的動向.臨精薬理 6:1111-1119,2003